OA12867A - Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. pepticulcers. - Google Patents
Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. pepticulcers. Download PDFInfo
- Publication number
- OA12867A OA12867A OA1200400327A OA1200400327A OA12867A OA 12867 A OA12867 A OA 12867A OA 1200400327 A OA1200400327 A OA 1200400327A OA 1200400327 A OA1200400327 A OA 1200400327A OA 12867 A OA12867 A OA 12867A
- Authority
- OA
- OAPI
- Prior art keywords
- group
- methyl
- substituents
- ethyl
- added
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002175086 | 2002-06-14 | ||
JP2003041085 | 2003-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA12867A true OA12867A (en) | 2006-09-15 |
Family
ID=29738411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200400327A OA12867A (en) | 2002-06-14 | 2003-06-13 | Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. pepticulcers. |
Country Status (19)
Country | Link |
---|---|
US (2) | US20060293371A1 (zh) |
EP (2) | EP1514870A4 (zh) |
JP (1) | JPWO2003106429A1 (zh) |
KR (1) | KR20050009751A (zh) |
CN (1) | CN1678315A (zh) |
AR (1) | AR040221A1 (zh) |
AT (1) | ATE437642T1 (zh) |
AU (2) | AU2003242390A1 (zh) |
BR (1) | BR0311801A (zh) |
CA (2) | CA2489361A1 (zh) |
DE (1) | DE60328603D1 (zh) |
IL (1) | IL165562A0 (zh) |
MX (1) | MXPA04012396A (zh) |
NO (1) | NO20050141L (zh) |
OA (1) | OA12867A (zh) |
PE (1) | PE20040563A1 (zh) |
PL (1) | PL373085A1 (zh) |
TW (1) | TW200307544A (zh) |
WO (2) | WO2003105845A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005105786A1 (en) | 2004-04-28 | 2005-11-10 | Hetero Drugs Limited | A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers |
WO2006090845A1 (ja) | 2005-02-25 | 2006-08-31 | Takeda Pharmaceutical Company Limited | 顆粒の製造方法 |
KR101148399B1 (ko) * | 2005-06-22 | 2012-05-23 | 일양약품주식회사 | 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물 |
US20100317689A1 (en) * | 2006-09-19 | 2010-12-16 | Garst Michael E | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
EP2252274A4 (en) | 2008-02-20 | 2011-05-11 | Univ Missouri | COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME |
US8722720B2 (en) | 2009-10-28 | 2014-05-13 | Newlink Genetics Corporation | Imidazole derivatives as IDO inhibitors |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
WO2016172436A1 (en) * | 2015-04-23 | 2016-10-27 | Temple University-Of The Commonwealth System Of Higher Education | Polycationic amphiphiles and polymers thereof as antimicrobial agents and methods using same |
IL283809B2 (en) | 2016-06-21 | 2024-01-01 | Univ Columbia | Compounds for use in a method for treating neuropathy, retinopathy, nephropathy or cardiomyopathy |
US11111216B2 (en) | 2016-10-26 | 2021-09-07 | Temple University-Of The Commonwealth System Of Higher Education | Polycationic amphiphiles as antimicrobial agents and methods using same |
AU2018307964B2 (en) | 2017-07-28 | 2023-11-16 | Applied Therapeutics Inc. | Compositions and methods for treating galactosemia |
JP2022531466A (ja) | 2019-05-07 | 2022-07-06 | ユニバーシティ オブ マイアミ | 遺伝性ニューロパチーおよび関連障害の処置および検出 |
JP7404561B2 (ja) * | 2020-06-17 | 2023-12-25 | イルドン ファーマシューティカル カンパニー リミテッド | 新規な酸分泌抑制剤及びその用途 |
IT202200001022A1 (it) * | 2022-01-21 | 2023-07-21 | Exo Lab Italia | Composti farmaceutici ibridi ottenuti mediante coniugazione di un inibitore delle pompe protoniche e un inibitore delle anidrasi carboniche |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
KR890000387B1 (ko) | 1984-09-24 | 1989-03-16 | 디 엎존 캄파니 | 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법 |
IL76839A (en) | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8505112D0 (sv) | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
US4965269A (en) | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US6542966B1 (en) * | 1998-07-16 | 2003-04-01 | Intel Corporation | Method and apparatus for managing temporal and non-temporal data in a single cache structure |
DE19832060C2 (de) * | 1998-07-16 | 2000-07-06 | Siemens Ag | Doppelbare Prozessoreinrichtung |
US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
HUP0202431A3 (en) * | 1999-04-09 | 2003-03-28 | Basf Ag | Prodrugs of thrombin inhibitors |
US6765019B1 (en) * | 1999-05-06 | 2004-07-20 | University Of Kentucky Research Foundation | Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
WO2002004452A2 (en) * | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
WO2002030920A1 (fr) | 2000-10-12 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Composes derives de benzimidazole, leur procede de production et leur utilisation |
AU2002303929B9 (en) * | 2001-05-31 | 2007-01-25 | E. R. Squibb & Sons, L.L.C. | Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
WO2003027098A1 (fr) | 2001-09-25 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Compose de benzymidazole, procede de production et d'utilisation de celui-ci |
-
2003
- 2003-06-13 WO PCT/JP2003/007546 patent/WO2003105845A1/en active Application Filing
- 2003-06-13 CA CA002489361A patent/CA2489361A1/en not_active Abandoned
- 2003-06-13 OA OA1200400327A patent/OA12867A/en unknown
- 2003-06-13 AU AU2003242390A patent/AU2003242390A1/en not_active Abandoned
- 2003-06-13 DE DE60328603T patent/DE60328603D1/de not_active Expired - Lifetime
- 2003-06-13 WO PCT/JP2003/007545 patent/WO2003106429A1/ja active Application Filing
- 2003-06-13 US US10/517,847 patent/US20060293371A1/en not_active Abandoned
- 2003-06-13 PE PE2003000593A patent/PE20040563A1/es not_active Application Discontinuation
- 2003-06-13 EP EP03733425A patent/EP1514870A4/en not_active Withdrawn
- 2003-06-13 CA CA002489470A patent/CA2489470A1/en not_active Abandoned
- 2003-06-13 AU AU2003242388A patent/AU2003242388A1/en not_active Abandoned
- 2003-06-13 TW TW092116056A patent/TW200307544A/zh unknown
- 2003-06-13 PL PL03373085A patent/PL373085A1/xx not_active Application Discontinuation
- 2003-06-13 MX MXPA04012396A patent/MXPA04012396A/es not_active Application Discontinuation
- 2003-06-13 US US10/517,633 patent/US7410981B2/en not_active Expired - Fee Related
- 2003-06-13 EP EP03733426A patent/EP1513527B1/en not_active Expired - Lifetime
- 2003-06-13 CN CNA038188953A patent/CN1678315A/zh active Pending
- 2003-06-13 JP JP2004513262A patent/JPWO2003106429A1/ja active Pending
- 2003-06-13 KR KR10-2004-7020371A patent/KR20050009751A/ko not_active Application Discontinuation
- 2003-06-13 AR ARP030102114A patent/AR040221A1/es not_active Application Discontinuation
- 2003-06-13 BR BR0311801-0A patent/BR0311801A/pt not_active IP Right Cessation
- 2003-06-13 AT AT03733426T patent/ATE437642T1/de not_active IP Right Cessation
-
2004
- 2004-12-05 IL IL16556204A patent/IL165562A0/xx unknown
-
2005
- 2005-01-11 NO NO20050141A patent/NO20050141L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20050009751A (ko) | 2005-01-25 |
EP1513527B1 (en) | 2009-07-29 |
EP1513527A1 (en) | 2005-03-16 |
EP1514870A1 (en) | 2005-03-16 |
IL165562A0 (en) | 2006-01-15 |
US20050222210A1 (en) | 2005-10-06 |
JPWO2003106429A1 (ja) | 2005-10-13 |
PL373085A1 (en) | 2005-08-08 |
BR0311801A (pt) | 2005-04-12 |
NO20050141L (no) | 2005-01-27 |
AU2003242388A1 (en) | 2003-12-31 |
MXPA04012396A (es) | 2005-06-17 |
TW200307544A (en) | 2003-12-16 |
US20060293371A1 (en) | 2006-12-28 |
CN1678315A (zh) | 2005-10-05 |
WO2003106429A1 (ja) | 2003-12-24 |
PE20040563A1 (es) | 2004-10-21 |
WO2003105845A1 (en) | 2003-12-24 |
ATE437642T1 (de) | 2009-08-15 |
CA2489470A1 (en) | 2003-12-24 |
US7410981B2 (en) | 2008-08-12 |
CA2489361A1 (en) | 2003-12-24 |
DE60328603D1 (de) | 2009-09-10 |
AU2003242390A1 (en) | 2003-12-31 |
NO20050141D0 (no) | 2005-01-11 |
EP1514870A4 (en) | 2006-08-23 |
AR040221A1 (es) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2277510B1 (en) | Controlled release preparation | |
OA12867A (en) | Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. pepticulcers. | |
US20040248941A1 (en) | Benzimidazone compound, process for producing the same, and use thereof | |
JP4578124B2 (ja) | 高濃度に活性成分を球形核に付着させた医薬組成物 | |
JP4493970B2 (ja) | 持続性製剤 | |
JP2004307457A (ja) | イミダゾール化合物、その製造方法およびその用途 |